Reboot chronic pain with transcranial direct current stimulation (tDCS)
Official title: Reboot Pain: Integrating Neuromodulation Into Clinical Care for Military and Veterans With Chronic Pain
Run by Emory University · NCT07411859 · Data updated 2026-11-12
This program will try daily, short tDCS sessions alongside Emory's Accelerated Behavioral Health Program to see if it reduces chronic pain in adult service members and veterans.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 89 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | February 16, 2026 |
| Main results expected | May 2027 |
| Study ends | May 2027 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07411859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult service members or veterans (18–89) enrolled in Emory's ABHP who report moderate-to-severe chronic pain (PEG ≥ 4), have an established primary care or pain provider, and have no contraindications are ideal candidates.
✕Probably not a fit
People with implanted pacemakers, seizure disorders, current use of excluded medications, new neurologic symptoms, pregnancy, or those not enrolled in Emory's ABHP are unlikely to be eligible or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This protocol adds non-drug brain stimulation (tDCS) to standard mental health care in the Emory Healthcare Veterans Program Accelerated Behavioral Health Program (ABHP) to target chronic pain. Adult service members and veterans (ages 18–89) enrolled in ABHP will self-administer roughly 20-minute tDCS sessions daily for two weeks, either in person at Emory's Executive Park Clinic or virtually with support. Pain will be tracked with the PEG scale, daily surveys, questionnaires, and standard clinical interviews, with follow-up assessments at 3, 6, and 12 months. Participants with implanted devices, seizure disorders, certain medications, pregnancy, or new neurologic symptoms are excluded due to safety concerns.
Why it matters
Potential benefit: If successful, adding tDCS to behavioral care could lower chronic pain and improve daily function without adding medications.
How similar studies have gone: Prior small trials of tDCS for chronic pain have shown mixed but occasionally promising results, so the approach has some supportive evidence but is not yet definitively proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Male or Female, 18-89 years old
* Treated on site for ABHP
* Willing to self-administer tDCS and complete the measures
* PEG pain intensity of 4 or more for most of the day at least 3 days per week
* Have an established PCP (Primary Care Provider) or pain management provider
Exclusion Criteria:
* Implanted pacemaker
* Seizure Disorder
* Pregnancy, if applicable
* Any new onset of the following:
* Balance Problems
* Difficulty walking
* Bladder incontinence
* Bowel incontinence
* Numbness
* Tingling
* Weakness
* Medical contraindications
* Current use of sodium channel blockers
* Lidocaine (OTC/transdermal delivery is ok)
* Mexiletine
* Amitriptyline; other tricyclic antidepressants
* Anti-epileptic medications: phenytoin, carbamazepine, lamotrigine, oxcarbazepine, rufinamide, lacosamide and eslicarbazepine acetate
* Current use of calcium channel blockers
* Current use of N-Methyl-D-aspartate receptor antagonists
* Ketamine
* Dextromethorphan
* Felbamate
* History of brain surgery
* History of brain tumor
* History of seizure disorder
* History of stroke
* Intracranial metal implantation
* Adults unable to consent
* Individuals who are not yet adults
* Prisoners
* Non-English speaking
Where it's running
-
The Emory Clinic
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Sheila Rauch, PhD — Emory University
- Study coordinator: Syreese Fuller
- Email: syreese.fuller@emory.edu
- Phone: 404-778-3188
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.